Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
Figure 2
Kaplan-Meier survival curves for glioma patients in high and low microRNA-17 (miR-17) expression groups. (a) The 5-year overall survival rate of glioma patients with high miR-17 expression was significantly lower than those with low miR-17 expression (). (b) The 5-year overall survival rate of grade I~II glioma patients with high miR-17 expression had no significant differences from those with low miR-17 expression (). (c) The 5-year overall survival rate of grade III~IV glioma patients with high miR-17 expression was significantly lower than those with low miR-17 expression ().
